首頁 > 市場調查報告書 > 醫療設備

導管藥物遞輸設備

市場調查報告書

商品編碼

1638727

製藥和醫療塑膠配件和管材市場機會、成長動力、產業趨勢分析和 2024 年至 2032 年預測

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年11月04日 | 出版商:

Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球製藥和醫療塑膠配件和管材市場價值為71.7億美元，預計2024年至2032年複合年成長率為6.1%，主要是由一次性醫療設備需求不斷成長推動的。對感染控制和交叉污染的日益擔憂促使醫療保健提供者擴大採用一次性設備，例如靜脈輸液器、導管和藥物輸送系統。這些設備配備塑膠配件和管道，提供安全、無菌的解決方案，有助於降低患者風險。

生物製藥的進步也加速了市場的成長，該產業更加重視生物製劑、疫苗和個人化治療。這種轉變增加了對無菌、無污染的流體處理系統的需求，其中塑膠配件和管道在確保藥物製造和轉移過程中的清潔和防止污染方面發揮著至關重要的作用。塑膠組件具有靈活性、耐化學性和一次性適用性，可支援不斷擴大的生物製藥生產，滿足全球醫療保健需求，推動創新和市場擴張。

2023 年，管材領域引領市場，產生40.1 億美元的收入，預計2024 年至2032 年將達到68.6 億美元左右。具有靈活性、耐用性和客製化選項，使其成為醫療環境中可靠、無菌流體處理的理想選擇。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	71.7 億美元
預測值	121.3 億美元
複合年成長率	6.1%

醫院和診所成為最大的最終用途領域，到2023 年佔據36% 的市場佔有率，預計到2032 年將以6.4% 的複合年成長率成長。和藥物管理和診斷，優先考慮無菌和感染控制。

在美國，用於製藥和醫療應用的塑膠配件和管材市場到2023 年將超過24.5 億美元，預計2024 年至2032 年複合年成長率為6.6%。和醫療機構網路。

產業生態系統分析
- 影響價值鏈的因素
- 利潤率分析
- 干擾
- 未來展望
- 製造商
- 經銷商
供應商格局
利潤率分析
重要新聞和舉措
監管環境
衝擊力
- 成長動力
  - 一次性醫療器材需求增加
  - 感染控制日益受到關注
  - 生物製藥的進展
  - 嚴格的監管標準
- 產業陷阱與挑戰
  - 環境問題
  - 污染風險
技術概覽
原料分析
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：依產品類型，2021-2032 年

主要趨勢
配件
- 連接器
- 適配器
- 閥門
- 魯爾接頭
- 快速連接配件
- 附刺配件
- 其他
管道
- 單腔管
- 多腔管
- 波紋管
- 編織管
- 連續油管
- 其他

第 6 章：市場估計與預測：按材料分類，2021-2032 年

主要趨勢
聚氯乙烯 (PVC)
聚乙烯（PE）
聚丙烯（PP）
聚四氟乙烯
矽酮
熱塑性彈性體 (TPE)
其他（尼龍、熱塑性聚氨酯等）

第 7 章：市場估計與預測：依最終用途，2021-2032 年

主要趨勢
醫院和診所
藥品廠商
生技公司
研究實驗室
醫療器材製造商

第 8 章：市場估計與預測：按配銷通路，2021-2032

主要趨勢
直接的
間接

第 9 章：市場估計與預測：按地區，2021-2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 俄羅斯
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 印尼
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 10 章：公司簡介

AP Extrusion
Atlas Copco
Eldon James
Freudenberg Medical
Navtar
New Age Industries
Nordson
Parker Hannifin
Polymer Solutions
Qosina
Raumedic
Saint-Gobain Performance Plastics
Smiths Medical
Tekni-Plex
Trelleborg

簡介目錄

Product Code: 12086

The Global Plastic Fittings And Tubing For Pharmaceutical And Medical Market was valued at USD 7.17 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032, primarily driven by the rising demand for disposable medical devices. Rising concerns about infection control and cross-contamination are prompting healthcare providers to increasingly adopt single-use devices, such as IV sets, catheters, and drug delivery systems. These devices, equipped with plastic fittings and tubing, offer safe, sterile solutions that help reduce patient risks.

Biopharmaceutical advancements are also accelerating market growth, with the sector focusing more on biologics, vaccines, and personalized treatments. This shift has increased the need for sterile, contamination-free fluid handling systems, where plastic fittings and tubing play a vital role in ensuring cleanliness and preventing contamination during drug manufacturing and transfer. Offering flexibility, chemical resistance, and suitability for single-use, plastic components support the expanding biopharmaceutical production that meets global healthcare demands, driving innovation and market expansion.

In 2023, the tubing segment led the market, generating USD 4.01 billion in revenue and is expected to reach around USD 6.86 billion from 2024 to 2032. Plastic tubing is integral for fluid transfer in IV systems, drug delivery, and diagnostic equipment due to its flexibility, durability, and customization options, making it ideal for reliable, sterile fluid handling in medical environments.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$7.17 Billion
Forecast Value	$12.13 Billion
CAGR	6.1%

Hospitals and clinics emerged as the largest end-use segment, capturing a 36% market share in 2023 and anticipated to grow at a CAGR of 6.4% through 2032. These facilities rely heavily on disposable plastic parts for fluid management, IV therapy, drug administration, and diagnostics, prioritizing sterility and infection control.

In the U.S., the plastic fittings and tubing market for pharmaceuticals and medical applications surpassed USD 2.45 billion in 2023, with an estimated CAGR of 6.6% from 2024 to 2032. The advanced U.S. healthcare system, with its extensive network of hospitals, clinics, and specialized centers, drives significant demand for medical supplies, including plastic components essential for safe and efficient patient care.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Key news & initiatives
3.5 Regulatory landscape
3.6 Impact forces
- 3.6.1 Growth drivers
  - 3.6.1.1 Increased demand for disposable medical devices
  - 3.6.1.2 Rising focus on infection control
  - 3.6.1.3 Advancements in biopharmaceuticals
  - 3.6.1.4 Stringent regulatory standards
- 3.6.2 Industry pitfalls & challenges
  - 3.6.2.1 Environmental concerns
  - 3.6.2.2 Risk of contamination
3.7 Technological overview
3.8 Raw Material analysis
3.9 Growth potential analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2032 (USD Billion) (Thousand Units)

5.1 Key trends
5.2 Fittings
- 5.2.1 Connectors
- 5.2.2 Adapters
- 5.2.3 Valves
- 5.2.4 Luer fittings
- 5.2.5 Quick-connect fittings
- 5.2.6 Barbed fittings
- 5.2.7 Others
5.3 Tubing
- 5.3.1 Single-lumen tubing
- 5.3.2 Multi-lumen tubing
- 5.3.3 Corrugated tubing
- 5.3.4 Braided tubing
- 5.3.5 Coiled tubing
- 5.3.6 Others

Chapter 6 Market Estimates & Forecast, By Materials, 2021-2032 (USD Billion) (Thousand Units)

6.1 Key trends
6.2 Polyvinyl Chloride (PVC)
6.3 Polyethylene (PE)
6.4 Polypropylene (PP)
6.5 PTFE
6.6 Silicone
6.7 Thermoplastic Elastomers (TPE)
6.8 Others (nylon, thermoplastic polyurethane, etc.)

Chapter 7 Market Estimates & Forecast, By End Use, 2021-2032 (USD Billion) (Thousand Units)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Pharmaceutical manufacturers
7.4 Biotechnology companies
7.5 Research laboratories
7.6 Medical device manufacturers

Chapter 8 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Billion) (Thousand Units)

8.1 Key trends
8.2 Direct
8.3 Indirect

Chapter 9 Market Estimates & Forecast, By Region, 2021-2032 (USD Billion) (Thousand Units)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Russia
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Indonesia
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE